Structure–function analysis of cytochromes P450 2B
In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure–function through determination of one ligand-free and two inhibitor-bound X-ray crystal structures of CYP2B4, which revealed many of the structural features required for binding ligands of different size and shape...
Saved in:
Published in | Biochimica et biophysica acta Vol. 1770; no. 3; pp. 402 - 412 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.03.2007
|
Subjects | |
Online Access | Get full text |
ISSN | 0304-4165 0006-3002 1872-8006 1878-2434 |
DOI | 10.1016/j.bbagen.2006.07.006 |
Cover
Loading…
Abstract | In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure–function through determination of one ligand-free and two inhibitor-bound X-ray crystal structures of CYP2B4, which revealed many of the structural features required for binding ligands of different size and shape. Large conformational changes of several plastic regions of CYP2B4 can dramatically reshape the active site of the enzyme to fit the size and shape of the bound ligand without perturbing the overall P450 fold. Solution biophysical studies using isothermal titration calorimetry (ITC) have revealed the large difference in the thermodynamic parameters of CYP2B4 in binding inhibitors of different ring chemistry and side chains. Other studies have revealed that the effects of site-specific mutations on steady-state kinetic parameters and mechanism-based inactivation are often substrate dependent. These findings agree with the structural data that the enzymes adopt different conformations to bind various ligands. Thus, the substrate specificity of an individual enzyme is determined not only by active site residues but also non-active site residues that modulate conformational changes that are important for substrate access and rearrangement of the active site to accommodate the bound substrate. |
---|---|
AbstractList | In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure-function through determination of one ligand-free and two inhibitor-bound X-ray crystal structures of CYP2B4, which revealed many of the structural features required for binding ligands of different size and shape. Large conformational changes of several plastic regions of CYP2B4 can dramatically reshape the active site of the enzyme to fit the size and shape of the bound ligand without perturbing the overall P450 fold. Solution biophysical studies using isothermal titration calorimetry (ITC) have revealed the large difference in the thermodynamic parameters of CYP2B4 in binding inhibitors of different ring chemistry and side chains. Other studies have revealed that the effects of site-specific mutations on steady-state kinetic parameters and mechanism-based inactivation are often substrate dependent. These findings agree with the structural data that the enzymes adopt different conformations to bind various ligands. Thus, the substrate specificity of an individual enzyme is determined not only by active site residues but also non-active site residues that modulate conformational changes that are important for substrate access and rearrangement of the active site to accommodate the bound substrate.In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure-function through determination of one ligand-free and two inhibitor-bound X-ray crystal structures of CYP2B4, which revealed many of the structural features required for binding ligands of different size and shape. Large conformational changes of several plastic regions of CYP2B4 can dramatically reshape the active site of the enzyme to fit the size and shape of the bound ligand without perturbing the overall P450 fold. Solution biophysical studies using isothermal titration calorimetry (ITC) have revealed the large difference in the thermodynamic parameters of CYP2B4 in binding inhibitors of different ring chemistry and side chains. Other studies have revealed that the effects of site-specific mutations on steady-state kinetic parameters and mechanism-based inactivation are often substrate dependent. These findings agree with the structural data that the enzymes adopt different conformations to bind various ligands. Thus, the substrate specificity of an individual enzyme is determined not only by active site residues but also non-active site residues that modulate conformational changes that are important for substrate access and rearrangement of the active site to accommodate the bound substrate. In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure–function through determination of one ligand-free and two inhibitor-bound X-ray crystal structures of CYP2B4, which revealed many of the structural features required for binding ligands of different size and shape. Large conformational changes of several plastic regions of CYP2B4 can dramatically reshape the active site of the enzyme to fit the size and shape of the bound ligand without perturbing the overall P450 fold. Solution biophysical studies using isothermal titration calorimetry (ITC) have revealed the large difference in the thermodynamic parameters of CYP2B4 in binding inhibitors of different ring chemistry and side chains. Other studies have revealed that the effects of site-specific mutations on steady-state kinetic parameters and mechanism-based inactivation are often substrate dependent. These findings agree with the structural data that the enzymes adopt different conformations to bind various ligands. Thus, the substrate specificity of an individual enzyme is determined not only by active site residues but also non-active site residues that modulate conformational changes that are important for substrate access and rearrangement of the active site to accommodate the bound substrate. |
Author | Zhao, Yonghong Halpert, James R. |
Author_xml | – sequence: 1 givenname: Yonghong surname: Zhao fullname: Zhao, Yonghong email: yozhao@utmb.edu – sequence: 2 givenname: James R. surname: Halpert fullname: Halpert, James R. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16935426$$D View this record in MEDLINE/PubMed https://www.osti.gov/biblio/910100$$D View this record in Osti.gov |
BookMark | eNqFkM9qFTEUh0Op2NvWNxAZN-5mmszkrwuhFrWFQgtt1yE3c8bmMjepSUa4O9_BN_RJzDgtBRd6Nr8svt8h5ztE-z54QOg1wQ3BhJ9smvXafAXftBjzBoumxB5aESnaWpb3PlrhDtOaEs4O0GFKG1yGKfYSHRCuOkZbvkL0JsfJ5inCrx8_h8nb7IKvjDfjLrlUhaGyuxzsfQxbSNU1ZbhqPx6jF4MZE7x6zCN09_nT7dl5fXn15eLs9LK2HRe5poPqBelET4wEiyUxljJCJah-YKLvJQVuZasMX_MyoATjSgyEKcsHyXB3hN4ue0PKTifrMth7G7wHm7UqFvDMvFuYhxi-TZCy3rpkYRyNhzAlzaWiUvxZ9uYRnNZb6PVDdFsTd_rJRQHoAtgYUoowPCNYz8r1Ri_K9axcY6FLlNr7v2rln2bWmKNx4__KH5YyFI3fHcT5SvAWehfnI_vg_r3gN3Q-nOM |
CitedBy_id | crossref_primary_10_1124_mol_107_042861 crossref_primary_10_1124_mol_107_039693 crossref_primary_10_1016_j_bpc_2016_05_007 crossref_primary_10_1021_ja403042k crossref_primary_10_1124_mol_115_102111 crossref_primary_10_1021_bi8011803 crossref_primary_10_1021_bi800926x crossref_primary_10_1124_dmd_116_071662 crossref_primary_10_3390_ijms23158498 crossref_primary_10_1016_j_dmpk_2018_01_001 crossref_primary_10_1021_bi800034b crossref_primary_10_1016_j_abb_2015_08_007 crossref_primary_10_1517_17425255_4_6_733 crossref_primary_10_1124_jpet_109_164350 crossref_primary_10_1016_j_bbagen_2016_03_028 crossref_primary_10_1002_humu_22295 crossref_primary_10_1021_acs_biochem_7b00097 crossref_primary_10_1021_acs_biochem_7b01024 crossref_primary_10_1021_tx800138v crossref_primary_10_1517_17425250903431040 crossref_primary_10_1021_acs_jcim_0c00482 crossref_primary_10_1021_bi101797v crossref_primary_10_1016_j_bbagen_2014_12_015 crossref_primary_10_1021_acs_biochem_5b01330 crossref_primary_10_1007_s00775_008_0368_5 crossref_primary_10_1016_j_taap_2013_12_005 crossref_primary_10_1021_tx7002504 crossref_primary_10_1074_jbc_M708582200 crossref_primary_10_1124_mol_109_062570 crossref_primary_10_1016_j_pharmthera_2009_05_011 crossref_primary_10_1093_jmammal_gyy039 crossref_primary_10_1074_jbc_M110_180646 crossref_primary_10_1007_s00775_009_0580_y crossref_primary_10_1074_jbc_M707470200 crossref_primary_10_1016_j_tplants_2014_11_002 crossref_primary_10_1124_jpet_109_158782 crossref_primary_10_1002_jmr_909 crossref_primary_10_1111_j_1742_4658_2011_08411_x crossref_primary_10_1016_j_abb_2009_11_026 crossref_primary_10_1021_bi300894z crossref_primary_10_1007_s10886_013_0335_7 crossref_primary_10_1124_dmd_122_000853 crossref_primary_10_1517_17425250802500028 crossref_primary_10_1128_mBio_00307_10 crossref_primary_10_1007_s00894_008_0294_z crossref_primary_10_1021_bi9003765 crossref_primary_10_1016_j_abb_2012_12_016 crossref_primary_10_1021_bi100914z crossref_primary_10_1124_dmd_111_042176 |
Cites_doi | 10.1016/j.abb.2004.03.014 10.1016/S1097-2765(00)80408-6 10.1016/j.abb.2003.12.035 10.1016/j.bbrc.2005.08.080 10.2174/1389200013338478 10.1021/tx020040b 10.1074/jbc.M212515200 10.1097/00008571-200310000-00005 10.1021/bi00180a040 10.1124/jpet.104.069757 10.1124/dmd.31.4.398 10.1016/S0959-440X(03)00003-4 10.1021/tx050100o 10.1124/jpet.301.1.160 10.2174/1389200013338612 10.1097/01213011-200512000-00004 10.1016/0167-4838(93)90238-M 10.1073/pnas.80.13.3958 10.1021/tx050256o 10.1006/abbi.2001.2574 10.1038/sj.tpj.6500157 10.1097/01.fpc.0000189797.03845.90 10.1021/bi034556l 10.1126/science.1079237 10.1074/jbc.M511464200 10.1124/jpet.103.050260 10.1124/dmd.105.003749 10.1074/jbc.M500158200 10.1016/j.bbrc.2005.08.192 10.1016/j.abb.2004.12.014 10.1074/jbc.M509696200 10.1074/jbc.M403349200 10.1124/dmd.105.004200 10.1021/bi0273922 10.1016/S0167-4838(00)00268-5 10.1086/499364 10.1124/jpet.300.2.549 10.1042/0264-6021:3390371 10.1073/pnas.2133986100 10.1124/jpet.104.071670 10.2133/dmpk.19.444 10.1124/dmd.30.1.86 10.1016/0003-9861(91)90121-X 10.1006/abbi.2001.2504 10.1074/jbc.M405427200 10.1086/499369 10.1021/tx020057u 10.1016/S0021-9258(18)54602-0 10.1016/S0021-9258(17)36209-9 10.1124/mol.59.3.475 10.1016/j.tibtech.2003.09.001 10.2174/1389200033489262 10.1080/10629360412331319835 |
ContentType | Journal Article |
Copyright | 2006 Elsevier B.V. |
Copyright_xml | – notice: 2006 Elsevier B.V. |
CorporateAuthor | Stanford Linear Accelerator Center (SLAC) |
CorporateAuthor_xml | – name: Stanford Linear Accelerator Center (SLAC) |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 OTOTI |
DOI | 10.1016/j.bbagen.2006.07.006 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic OSTI.GOV |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1872-8006 1878-2434 |
EndPage | 412 |
ExternalDocumentID | 910100 16935426 10_1016_j_bbagen_2006_07_006 S0304416506002030 |
Genre | Journal Article Review Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIEHS NIH HHS grantid: ES06676 – fundername: NIEHS NIH HHS grantid: ES03619 – fundername: NIEHS NIH HHS grantid: T32-ES07254 |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABEFU ABFNM ABGSF ABMAC ABUDA ABXDB ABYKQ ACDAQ ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 R2- ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UQL WH7 WUQ XJT XPP ~G- AAHBH AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH -~X .55 .GJ AAYJJ ABJNI AFFNX AI. CGR CUY CVF ECM EIF F5P H~9 K-O MVM NPM PKN RIG TWZ UHS VH1 X7M Y6R YYP ZE2 ZGI ~KM 7X8 OTOTI |
ID | FETCH-LOGICAL-c367t-4f9d7137d1a8ec081ac45148e9df57dd84e6c829a6b6666e975697f159c6f8503 |
IEDL.DBID | AIKHN |
ISSN | 0304-4165 0006-3002 |
IngestDate | Fri May 19 01:41:38 EDT 2023 Thu Jul 10 22:54:24 EDT 2025 Wed Feb 19 01:49:15 EST 2025 Thu Apr 24 23:07:35 EDT 2025 Tue Jul 01 00:21:52 EDT 2025 Fri Feb 23 02:32:39 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | PR Cymal-5 DTT Δ S 4CPI 17EE Function P450 or CYP Substrate specificity QM Structure tTEPA Cytochrome P450 BEI S.D 1PI EDTA CYP2B1dH (CYP2B4dH, CYP2B6dH, and CYP2B11dH) 4PI 7-EFC DMZ Δ H CYP2B CPA QSAR 1BI ITC MES 1CPI 7-BR Conformation |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c367t-4f9d7137d1a8ec081ac45148e9df57dd84e6c829a6b6666e975697f159c6f8503 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 USDOE SLAC-REPRINT-2007-170 AC02-76SF00515 |
PMID | 16935426 |
PQID | 68948750 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | osti_scitechconnect_910100 proquest_miscellaneous_68948750 pubmed_primary_16935426 crossref_primary_10_1016_j_bbagen_2006_07_006 crossref_citationtrail_10_1016_j_bbagen_2006_07_006 elsevier_sciencedirect_doi_10_1016_j_bbagen_2006_07_006 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007-03-00 |
PublicationDateYYYYMMDD | 2007-03-01 |
PublicationDate_xml | – month: 03 year: 2007 text: 2007-03-00 |
PublicationDecade | 2000 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands – name: United States |
PublicationTitle | Biochimica et biophysica acta |
PublicationTitleAlternate | Biochim Biophys Acta |
PublicationYear | 2007 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Kumar, Scott, Liu, Halpert (bib15) 2003; 278 Wester, Yano, Schoch, Yang, Griffin, Stout, Johnson (bib35) 2004; 279 Ribaudo, Haas, Tierney, Kim, Wilkinson, Gulick, Clifford, Marzolini, Fletcher, Tashima, Kuritzkes, Acosta (bib26) 2006; 42 Wang, Sonnerborg, Rane, Josephson, Lundgren, Stahle, Ingelman-Sundberg (bib27) 2006; 16 Gasser, Negishi, Philpot (bib6) 1988; 33 Lin, Kent, Hollenberg (bib46) 2002; 301 Jinno, Tanaka-Kagawa, Ohno, Makino, Matsushima, Hanioka, Ando (bib56) 2003; 31 Sridar, Harleton, Hollenberg (bib20) 2005; 338 Kedzie, Grimm, Chen, Halpert (bib3) 1993; 1164 Wang, Negishi (bib1) 2003; 4 Kedzie, Balfour, Escobar, Grimm, He, Pepperl, Regan, Stevens, Halpert (bib4) 1991; 266 Scott, He, Halpert (bib17) 2002; 15 Kent, Lin, Mills, Regal, Hollenberg (bib19) 2006; 19 Norinder (bib36) 2005; 16 Nolan, Phillips, Mallal (bib55) 2006; 42 Mizukami, Sobawa, Suwa, Muramatsu, Fujii-Kuriyama (bib5) 1983; 80 Scott, White, He, Johnson, Stout, Halpert (bib12) 2004; 279 Li, Liu, Scott, Grater, Halpert, Luo, Shen, Jiang (bib40) 2005; 33 He, Luo, Klekotka, Burnett, Halpert (bib48) 1994; 33 Kumar, Chen, Waxman, Halpert (bib41) 2005; 280 Spatzenegger, Wang, He, Wester, Johnson, Halpert (bib38) 2001; 59 Lin, Zhang, Waskell, Hollenberg (bib47) 2003; 306 Kumar, Halpert (bib23) 2005; 338 Wester, Johnson, Marques-Soares, Dijols, Dansette, Mansuy, Stout (bib32) 2003; 42 Turner (bib54) 2003; 21 Bumpus, Sridar, Kent, Hollenberg (bib29) 2005; 33 Kent, Mills, Rajnarayanan, Alworth, Hollenberg (bib45) 2002; 300 Kent, Juschyshyn, Hollenberg (bib43) 2001; 2 Zhao, White, Muralidhara, Sun, Halpert, Stout (bib13) 2006; 281 Lin, Kent, Zhang, Waskell, Hollenberg (bib22) 2004; 311 Domanski, Halpert (bib7) 2001; 2 Scott, Spatzenegger, Halpert (bib10) 2001; 395 Szklarz, Halpert (bib44) 1998; 26 Domanski, He, Scott, Wang, Halpert (bib33) 2001; 394 Iwasaki, Yoshimura, Asahi, Saito, Sakai, Morita, Takenaka, Inoda, Kashiyama, Aoyama, Nakabayashi, Omori, Kuwabara, Izumi, Nakamura, Takanaka, Nakayama, Takeuchi, Nakamura, Kametani, Terauchi, Hashizume, Nagayama, Kume, Achira, Kawai, Kawashiro, Nakamura, Nakai, Kagayama, Shiraga, Niwa, Yoshimura, Morita, Ohsawa, Tani, Osawa, Ida, Noguchi (bib30) 2004; 19 Kedzie, Philpot, Halpert (bib2) 1991; 291 Muralidhara, Negi, Chin, Braun, Halpert (bib14) 2006; 281 Xie, Yasar, Lundgren, Griskevicius, Terelius, Hassan, Rane (bib25) 2003; 3 von Weymarn, Blobaum, Hollenberg (bib49) 2004; 425 Weber, Salemme (bib37) 2003; 13 Wang, Halpert (bib39) 2002; 30 Kirchheiner, Klein, Meineke, Sasse, Zanger, Murdter, Roots, Brockmoller (bib24) 2003; 13 Lin, Zhang, Waskell, Hollenberg (bib51) 2005; 18 Scott, He, Wester, White, Chin, Halpert, Johnson, Stout (bib11) 2003; 100 Noble, Miles, Chapman, Lysek, MacKay, Reid, Hanzlik, Munro (bib42) 1999; 339 Von Weymarn, Sridar, Hollenberg (bib21) 2004; 311 Schoemaker, Mink, Wubbolts (bib52) 2003; 299 Williams, Cosme, Sridhar, Johnson, McRee (bib9) 2000; 5 Li, Schwaneberg, Fischer, Schmitt, Pleiss, Lutz-Wahl, Schmid (bib53) 2001; 1545 Lin, Kent, Zhang, Waskell, Hollenberg (bib50) 2003; 16 Honma, Li, Liu, Scott, Halpert (bib16) 2005; 435 Wester, Johnson, Marques-Soares, Dansette, Mansuy, Stout (bib31) 2003; 42 Klein, Lang, Saussele, Barbosa-Sicard, Schunck, Eichelbaum, Schwab, Zanger (bib28) 2005; 15 Poulos, Finzel, Gunsalus, Wagner, Kraut (bib8) 1985; 260 Scott, Liu, Qun He, Li, Halpert (bib18) 2004; 423 Spatzenegger (10.1016/j.bbagen.2006.07.006_bib38) 2001; 59 Scott (10.1016/j.bbagen.2006.07.006_bib18) 2004; 423 Scott (10.1016/j.bbagen.2006.07.006_bib12) 2004; 279 Norinder (10.1016/j.bbagen.2006.07.006_bib36) 2005; 16 Kedzie (10.1016/j.bbagen.2006.07.006_bib4) 1991; 266 Bumpus (10.1016/j.bbagen.2006.07.006_bib29) 2005; 33 Lin (10.1016/j.bbagen.2006.07.006_bib22) 2004; 311 Klein (10.1016/j.bbagen.2006.07.006_bib28) 2005; 15 Jinno (10.1016/j.bbagen.2006.07.006_bib56) 2003; 31 Wang (10.1016/j.bbagen.2006.07.006_bib1) 2003; 4 Scott (10.1016/j.bbagen.2006.07.006_bib17) 2002; 15 He (10.1016/j.bbagen.2006.07.006_bib48) 1994; 33 Kedzie (10.1016/j.bbagen.2006.07.006_bib2) 1991; 291 Kent (10.1016/j.bbagen.2006.07.006_bib45) 2002; 300 Sridar (10.1016/j.bbagen.2006.07.006_bib20) 2005; 338 Ribaudo (10.1016/j.bbagen.2006.07.006_bib26) 2006; 42 von Weymarn (10.1016/j.bbagen.2006.07.006_bib49) 2004; 425 Wester (10.1016/j.bbagen.2006.07.006_bib35) 2004; 279 Szklarz (10.1016/j.bbagen.2006.07.006_bib44) 1998; 26 Nolan (10.1016/j.bbagen.2006.07.006_bib55) 2006; 42 Honma (10.1016/j.bbagen.2006.07.006_bib16) 2005; 435 Lin (10.1016/j.bbagen.2006.07.006_bib47) 2003; 306 Lin (10.1016/j.bbagen.2006.07.006_bib50) 2003; 16 Kumar (10.1016/j.bbagen.2006.07.006_bib23) 2005; 338 Wester (10.1016/j.bbagen.2006.07.006_bib32) 2003; 42 Schoemaker (10.1016/j.bbagen.2006.07.006_bib52) 2003; 299 Von Weymarn (10.1016/j.bbagen.2006.07.006_bib21) 2004; 311 Poulos (10.1016/j.bbagen.2006.07.006_bib8) 1985; 260 Zhao (10.1016/j.bbagen.2006.07.006_bib13) 2006; 281 Lin (10.1016/j.bbagen.2006.07.006_bib46) 2002; 301 Iwasaki (10.1016/j.bbagen.2006.07.006_bib30) 2004; 19 Mizukami (10.1016/j.bbagen.2006.07.006_bib5) 1983; 80 Wester (10.1016/j.bbagen.2006.07.006_bib31) 2003; 42 Kent (10.1016/j.bbagen.2006.07.006_bib43) 2001; 2 Weber (10.1016/j.bbagen.2006.07.006_bib37) 2003; 13 Wang (10.1016/j.bbagen.2006.07.006_bib39) 2002; 30 Scott (10.1016/j.bbagen.2006.07.006_bib11) 2003; 100 Gasser (10.1016/j.bbagen.2006.07.006_bib6) 1988; 33 Kedzie (10.1016/j.bbagen.2006.07.006_bib3) 1993; 1164 Lin (10.1016/j.bbagen.2006.07.006_bib51) 2005; 18 Li (10.1016/j.bbagen.2006.07.006_bib53) 2001; 1545 Xie (10.1016/j.bbagen.2006.07.006_bib25) 2003; 3 Muralidhara (10.1016/j.bbagen.2006.07.006_bib14) 2006; 281 Wang (10.1016/j.bbagen.2006.07.006_bib27) 2006; 16 Williams (10.1016/j.bbagen.2006.07.006_bib9) 2000; 5 Kumar (10.1016/j.bbagen.2006.07.006_bib15) 2003; 278 Domanski (10.1016/j.bbagen.2006.07.006_bib7) 2001; 2 Kent (10.1016/j.bbagen.2006.07.006_bib19) 2006; 19 Scott (10.1016/j.bbagen.2006.07.006_bib10) 2001; 395 Li (10.1016/j.bbagen.2006.07.006_bib40) 2005; 33 Kirchheiner (10.1016/j.bbagen.2006.07.006_bib24) 2003; 13 Domanski (10.1016/j.bbagen.2006.07.006_bib33) 2001; 394 Turner (10.1016/j.bbagen.2006.07.006_bib54) 2003; 21 Kumar (10.1016/j.bbagen.2006.07.006_bib41) 2005; 280 Noble (10.1016/j.bbagen.2006.07.006_bib42) 1999; 339 |
References_xml | – volume: 435 start-page: 157 year: 2005 end-page: 165 ident: bib16 article-title: Functional role of residues in the helix B′ region of cytochrome P450 2B1 publication-title: Arch. Biochem. Biophys. – volume: 299 start-page: 1694 year: 2003 end-page: 1697 ident: bib52 article-title: Dispelling the myths—Biocatalysis in industrial synthesis publication-title: Science – volume: 31 start-page: 398 year: 2003 end-page: 403 ident: bib56 article-title: Functional characterization of cytochrome P450 2B6 allelic variants publication-title: Drug Metab. Dispos. – volume: 300 start-page: 549 year: 2002 end-page: 558 ident: bib45 article-title: Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites publication-title: J. Pharmacol. Exp. Ther. – volume: 338 start-page: 456 year: 2005 end-page: 464 ident: bib23 article-title: Use of directed evolution of mammalian cytochromes P450 for investigating the molecular basis of enzyme function and generating novel biocatalysts publication-title: Biochem. Biophys. Res. Commun. – volume: 339 start-page: 371 year: 1999 end-page: 379 ident: bib42 article-title: Roles of key active-site residues in flavocytochrome P450 BM3 publication-title: Biochem. J. – volume: 266 start-page: 22515 year: 1991 end-page: 22521 ident: bib4 article-title: Molecular basis for a functionally unique cytochrome P450IIB1 variant publication-title: J. Biol. Chem. – volume: 26 start-page: 1179 year: 1998 end-page: 1184 ident: bib44 article-title: Molecular basis of P450 inhibition and activation: implications for drug development and drug therapy publication-title: Drug Metab. Dispos. – volume: 33 start-page: 4419 year: 1994 end-page: 4424 ident: bib48 article-title: Structural determinants of cytochrome P450 2B1 specificity: evidence for five substrate recognition sites publication-title: Biochemistry – volume: 1164 start-page: 124 year: 1993 end-page: 132 ident: bib3 article-title: Hybrid enzymes for structure–function analysis of cytochrome P-450 2B11 publication-title: Biochim. Biophys. Acta – volume: 100 start-page: 13196 year: 2003 end-page: 13201 ident: bib11 article-title: An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 279 start-page: 27294 year: 2004 end-page: 27301 ident: bib12 article-title: Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl)imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding publication-title: J. Biol. Chem. – volume: 311 start-page: 855 year: 2004 end-page: 863 ident: bib22 article-title: The functional role of threonine-205 in the mechanism-based inactivation of P450 2B1 by two ethynyl substrates: the importance of the F helix in catalysis publication-title: J. Pharmacol. Exp. Ther. – volume: 5 start-page: 121 year: 2000 end-page: 131 ident: bib9 article-title: Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity publication-title: Mol. Cell – volume: 278 start-page: 17178 year: 2003 end-page: 17184 ident: bib15 article-title: A rational approach to re-engineer cytochrome P450 2B1 regioselectivity based on the crystal structure of cytochrome P450 2C5 publication-title: J. Biol. Chem. – volume: 16 start-page: 191 year: 2006 end-page: 198 ident: bib27 article-title: Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz publication-title: Pharmacogenet. Genomics – volume: 338 start-page: 386 year: 2005 end-page: 393 ident: bib20 article-title: Roles of the threonine 407, aspartic acid 417, and threonine 419 residues in P450 2B1 in metabolism publication-title: Biochem. Biophys. Res. Commun. – volume: 4 start-page: 515 year: 2003 end-page: 525 ident: bib1 article-title: Transcriptional regulation of cytochrome P4502B genes by nuclear receptors publication-title: Curr. Drug Metab. – volume: 42 start-page: 6370 year: 2003 end-page: 6379 ident: bib31 article-title: Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes publication-title: Biochemistry – volume: 16 start-page: 129 year: 2003 end-page: 136 ident: bib50 article-title: Mutation of tyrosine 190 to alanine eliminates the inactivation of cytochrome P450 2B1 by peroxynitrite publication-title: Chem. Res. Toxicol. – volume: 1545 start-page: 114 year: 2001 end-page: 121 ident: bib53 article-title: Rational evolution of a medium chain-specific cytochrome P-450 BM-3 variant publication-title: Biochim. Biophys. Acta – volume: 33 start-page: 795 year: 2005 end-page: 802 ident: bib29 article-title: The naturally occurring cytochrome P450 (P450) 2B6 K262R mutant of P450 2B6 exhibits alterations in substrate metabolism and inactivation publication-title: Drug Metab. Dispos. – volume: 15 start-page: 1407 year: 2002 end-page: 1413 ident: bib17 article-title: Substrate routes to the buried active site may vary among cytochromes P450: mutagenesis of the F–G region in P450 2B1 publication-title: Chem. Res. Toxicol. – volume: 42 start-page: 9335 year: 2003 end-page: 9345 ident: bib32 article-title: Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 A resolution: evidence for an induced fit model of substrate binding publication-title: Biochemistry – volume: 394 start-page: 21 year: 2001 end-page: 28 ident: bib33 article-title: The role of cytochrome B1 substrate recognition site residues 115, 294, 297, 298, and 362 in the oxidation of steroids and 7-alkoxycoumarins publication-title: Arch. Biochem. Biophys. – volume: 21 start-page: 474 year: 2003 end-page: 478 ident: bib54 article-title: Directed evolution of enzymes for applied biocatalysis publication-title: Trends Biotechnol. – volume: 30 start-page: 86 year: 2002 end-page: 95 ident: bib39 article-title: Combined three-dimensional quantitative structure–activity relationship analysis of cytochrome P450 2B6 substrates and protein homology modeling publication-title: Drug Metab. Dispos. – volume: 19 start-page: 279 year: 2006 end-page: 287 ident: bib19 article-title: Identification of 17-alpha-ethynylestradiol-modified active site, peptides and glutathione conjugates formed during metabolism, and inactivation of P450s 2B1 and 2B6 publication-title: Chem. Res. Toxicol. – volume: 13 start-page: 619 year: 2003 end-page: 626 ident: bib24 article-title: Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6 publication-title: Pharmacogenetics – volume: 260 start-page: 16122 year: 1985 end-page: 16130 ident: bib8 article-title: The 2.6-A crystal structure of publication-title: J. Biol. Chem. – volume: 281 start-page: 8051 year: 2006 end-page: 8061 ident: bib14 article-title: Conformational flexibility of mammalian cytochrome P4502B4 in binding imidazole inhibitors with different ring chemistry and side chains—Solution thermodynamics and molecular modeling publication-title: J. Biol. Chem. – volume: 42 start-page: 408 year: 2006 end-page: 410 ident: bib55 article-title: Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance publication-title: Clin. Infect. Dis. – volume: 281 start-page: 5973 year: 2006 end-page: 5981 ident: bib13 article-title: Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction publication-title: J. Biol. Chem. – volume: 18 start-page: 1203 year: 2005 end-page: 1210 ident: bib51 article-title: The highly conserved Glu149 and Tyr190 residues contribute to peroxynitrite-mediated nitrotyrosine formation and the catalytic activity of cytochrome P450 2B1 publication-title: Chem. Res. Toxicol. – volume: 59 start-page: 475 year: 2001 end-page: 484 ident: bib38 article-title: Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles publication-title: Mol. Pharmacol. – volume: 306 start-page: 744 year: 2003 end-page: 751 ident: bib47 article-title: Threonine-205 in the F helix of p450 2B1 contributes to androgen 16 beta-hydroxylation activity and mechanism-based inactivation publication-title: J. Pharmacol. Exp. Ther. – volume: 2 start-page: 215 year: 2001 end-page: 243 ident: bib43 article-title: Mechanism-based inactivators as probes of cytochrome P450 structure and function publication-title: Curr. Drug Metab. – volume: 15 start-page: 861 year: 2005 end-page: 873 ident: bib28 article-title: Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz publication-title: Pharmacogenet. Genomics – volume: 301 start-page: 160 year: 2002 end-page: 167 ident: bib46 article-title: Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein publication-title: J. Pharmacol. Exp. Ther. – volume: 80 start-page: 3958 year: 1983 end-page: 3962 ident: bib5 article-title: Gene structure of a phenobarbital-inducible cytochrome P-450 in rat liver publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 2 start-page: 117 year: 2001 end-page: 137 ident: bib7 article-title: Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis publication-title: Curr. Drug Metab. – volume: 33 start-page: 910 year: 2005 end-page: 919 ident: bib40 article-title: Possible pathway(s) of testosterone egress from the active site of cytochrome P450 2B1: a steered molecular dynamics simulation publication-title: Drug Metab. Dispos. – volume: 395 start-page: 57 year: 2001 end-page: 68 ident: bib10 article-title: A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function publication-title: Arch. Biochem. Biophys. – volume: 291 start-page: 176 year: 1991 end-page: 186 ident: bib2 article-title: Functional expression of mammalian cytochromes P450IIB in the yeast publication-title: Arch. Biochem. Biophys. – volume: 42 start-page: 401 year: 2006 end-page: 407 ident: bib26 article-title: Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an adult AIDS clinical trials group study publication-title: Clin. Infect. Dis. – volume: 33 start-page: 22 year: 1988 end-page: 30 ident: bib6 article-title: Primary structures of multiple forms of cytochrome P450 isozyme 2 derived from rabbit pulmonary and hepatic cDNAs publication-title: Mol. Pharmacol. – volume: 279 start-page: 35630 year: 2004 end-page: 35637 ident: bib35 article-title: The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution publication-title: J. Biol. Chem. – volume: 280 start-page: 19569 year: 2005 end-page: 19575 ident: bib41 article-title: Directed evolution of mammalian cytochrome P450 2B1: mutations outside of the active site enhance the metabolism of several substrates, including the anticancer prodrugs cyclophosphamide and ifosfamide publication-title: J. Biol. Chem. – volume: 16 start-page: 1 year: 2005 end-page: 11 ident: bib36 article-title: In silico modelling of ADMET—a minireview of work from 2000 to 2004 publication-title: SAR QSAR Environ. Res. – volume: 423 start-page: 266 year: 2004 end-page: 276 ident: bib18 article-title: Mutagenesis and molecular dynamics suggest structural and functional roles for residues in the N-terminal portion of the cytochrome P450 2B1 I helix publication-title: Arch. Biochem. Biophys. – volume: 3 start-page: 53 year: 2003 end-page: 61 ident: bib25 article-title: Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation publication-title: Pharmacogenomics J. – volume: 425 start-page: 95 year: 2004 end-page: 105 ident: bib49 article-title: The mechanism-based inactivation of P450 2B4 by tert-butyl 1-methyl-2-propynyl ether: structural determination of the adducts to the p450 heme publication-title: Arch. Biochem. Biophys. – volume: 311 start-page: 71 year: 2004 end-page: 79 ident: bib21 article-title: Identification of amino acid residues involved in the inactivation of cytochrome P450 2B1 by two acetylenic compounds: the role of three residues in nonsubstrate recognition sites publication-title: J. Pharmacol. Exp. Ther. – volume: 19 start-page: 444 year: 2004 end-page: 4452 ident: bib30 article-title: Functional characterization of single nucleotide polymorphisms with amino acid substitution in CYP1A2, CYP2A6, and CYP2B6 found in the Japanese population publication-title: Drug Metab. Pharmacokinet. – volume: 13 start-page: 115 year: 2003 end-page: 121 ident: bib37 article-title: Applications of calorimetric methods to drug discovery and the study of protein interactions publication-title: Curr. Opin. Struct. Biol. – volume: 425 start-page: 95 year: 2004 ident: 10.1016/j.bbagen.2006.07.006_bib49 article-title: The mechanism-based inactivation of P450 2B4 by tert-butyl 1-methyl-2-propynyl ether: structural determination of the adducts to the p450 heme publication-title: Arch. Biochem. Biophys. doi: 10.1016/j.abb.2004.03.014 – volume: 5 start-page: 121 year: 2000 ident: 10.1016/j.bbagen.2006.07.006_bib9 article-title: Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity publication-title: Mol. Cell doi: 10.1016/S1097-2765(00)80408-6 – volume: 423 start-page: 266 year: 2004 ident: 10.1016/j.bbagen.2006.07.006_bib18 article-title: Mutagenesis and molecular dynamics suggest structural and functional roles for residues in the N-terminal portion of the cytochrome P450 2B1 I helix publication-title: Arch. Biochem. Biophys. doi: 10.1016/j.abb.2003.12.035 – volume: 33 start-page: 22 year: 1988 ident: 10.1016/j.bbagen.2006.07.006_bib6 article-title: Primary structures of multiple forms of cytochrome P450 isozyme 2 derived from rabbit pulmonary and hepatic cDNAs publication-title: Mol. Pharmacol. – volume: 338 start-page: 456 year: 2005 ident: 10.1016/j.bbagen.2006.07.006_bib23 article-title: Use of directed evolution of mammalian cytochromes P450 for investigating the molecular basis of enzyme function and generating novel biocatalysts publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2005.08.080 – volume: 2 start-page: 215 year: 2001 ident: 10.1016/j.bbagen.2006.07.006_bib43 article-title: Mechanism-based inactivators as probes of cytochrome P450 structure and function publication-title: Curr. Drug Metab. doi: 10.2174/1389200013338478 – volume: 16 start-page: 129 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib50 article-title: Mutation of tyrosine 190 to alanine eliminates the inactivation of cytochrome P450 2B1 by peroxynitrite publication-title: Chem. Res. Toxicol. doi: 10.1021/tx020040b – volume: 278 start-page: 17178 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib15 article-title: A rational approach to re-engineer cytochrome P450 2B1 regioselectivity based on the crystal structure of cytochrome P450 2C5 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M212515200 – volume: 13 start-page: 619 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib24 article-title: Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6 publication-title: Pharmacogenetics doi: 10.1097/00008571-200310000-00005 – volume: 33 start-page: 4419 year: 1994 ident: 10.1016/j.bbagen.2006.07.006_bib48 article-title: Structural determinants of cytochrome P450 2B1 specificity: evidence for five substrate recognition sites publication-title: Biochemistry doi: 10.1021/bi00180a040 – volume: 311 start-page: 71 year: 2004 ident: 10.1016/j.bbagen.2006.07.006_bib21 article-title: Identification of amino acid residues involved in the inactivation of cytochrome P450 2B1 by two acetylenic compounds: the role of three residues in nonsubstrate recognition sites publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.104.069757 – volume: 31 start-page: 398 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib56 article-title: Functional characterization of cytochrome P450 2B6 allelic variants publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.31.4.398 – volume: 13 start-page: 115 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib37 article-title: Applications of calorimetric methods to drug discovery and the study of protein interactions publication-title: Curr. Opin. Struct. Biol. doi: 10.1016/S0959-440X(03)00003-4 – volume: 18 start-page: 1203 year: 2005 ident: 10.1016/j.bbagen.2006.07.006_bib51 article-title: The highly conserved Glu149 and Tyr190 residues contribute to peroxynitrite-mediated nitrotyrosine formation and the catalytic activity of cytochrome P450 2B1 publication-title: Chem. Res. Toxicol. doi: 10.1021/tx050100o – volume: 301 start-page: 160 year: 2002 ident: 10.1016/j.bbagen.2006.07.006_bib46 article-title: Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.301.1.160 – volume: 2 start-page: 117 year: 2001 ident: 10.1016/j.bbagen.2006.07.006_bib7 article-title: Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis publication-title: Curr. Drug Metab. doi: 10.2174/1389200013338612 – volume: 15 start-page: 861 year: 2005 ident: 10.1016/j.bbagen.2006.07.006_bib28 article-title: Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz publication-title: Pharmacogenet. Genomics doi: 10.1097/01213011-200512000-00004 – volume: 1164 start-page: 124 year: 1993 ident: 10.1016/j.bbagen.2006.07.006_bib3 article-title: Hybrid enzymes for structure–function analysis of cytochrome P-450 2B11 publication-title: Biochim. Biophys. Acta doi: 10.1016/0167-4838(93)90238-M – volume: 80 start-page: 3958 year: 1983 ident: 10.1016/j.bbagen.2006.07.006_bib5 article-title: Gene structure of a phenobarbital-inducible cytochrome P-450 in rat liver publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.80.13.3958 – volume: 19 start-page: 279 year: 2006 ident: 10.1016/j.bbagen.2006.07.006_bib19 article-title: Identification of 17-alpha-ethynylestradiol-modified active site, peptides and glutathione conjugates formed during metabolism, and inactivation of P450s 2B1 and 2B6 publication-title: Chem. Res. Toxicol. doi: 10.1021/tx050256o – volume: 395 start-page: 57 year: 2001 ident: 10.1016/j.bbagen.2006.07.006_bib10 article-title: A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function publication-title: Arch. Biochem. Biophys. doi: 10.1006/abbi.2001.2574 – volume: 3 start-page: 53 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib25 article-title: Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation publication-title: Pharmacogenomics J. doi: 10.1038/sj.tpj.6500157 – volume: 16 start-page: 191 year: 2006 ident: 10.1016/j.bbagen.2006.07.006_bib27 article-title: Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz publication-title: Pharmacogenet. Genomics doi: 10.1097/01.fpc.0000189797.03845.90 – volume: 42 start-page: 9335 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib32 article-title: Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 A resolution: evidence for an induced fit model of substrate binding publication-title: Biochemistry doi: 10.1021/bi034556l – volume: 299 start-page: 1694 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib52 article-title: Dispelling the myths—Biocatalysis in industrial synthesis publication-title: Science doi: 10.1126/science.1079237 – volume: 281 start-page: 5973 year: 2006 ident: 10.1016/j.bbagen.2006.07.006_bib13 article-title: Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction publication-title: J. Biol. Chem. doi: 10.1074/jbc.M511464200 – volume: 306 start-page: 744 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib47 article-title: Threonine-205 in the F helix of p450 2B1 contributes to androgen 16 beta-hydroxylation activity and mechanism-based inactivation publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.103.050260 – volume: 33 start-page: 795 year: 2005 ident: 10.1016/j.bbagen.2006.07.006_bib29 article-title: The naturally occurring cytochrome P450 (P450) 2B6 K262R mutant of P450 2B6 exhibits alterations in substrate metabolism and inactivation publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.105.003749 – volume: 280 start-page: 19569 year: 2005 ident: 10.1016/j.bbagen.2006.07.006_bib41 article-title: Directed evolution of mammalian cytochrome P450 2B1: mutations outside of the active site enhance the metabolism of several substrates, including the anticancer prodrugs cyclophosphamide and ifosfamide publication-title: J. Biol. Chem. doi: 10.1074/jbc.M500158200 – volume: 338 start-page: 386 year: 2005 ident: 10.1016/j.bbagen.2006.07.006_bib20 article-title: Roles of the threonine 407, aspartic acid 417, and threonine 419 residues in P450 2B1 in metabolism publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2005.08.192 – volume: 435 start-page: 157 year: 2005 ident: 10.1016/j.bbagen.2006.07.006_bib16 article-title: Functional role of residues in the helix B′ region of cytochrome P450 2B1 publication-title: Arch. Biochem. Biophys. doi: 10.1016/j.abb.2004.12.014 – volume: 281 start-page: 8051 year: 2006 ident: 10.1016/j.bbagen.2006.07.006_bib14 article-title: Conformational flexibility of mammalian cytochrome P4502B4 in binding imidazole inhibitors with different ring chemistry and side chains—Solution thermodynamics and molecular modeling publication-title: J. Biol. Chem. doi: 10.1074/jbc.M509696200 – volume: 279 start-page: 27294 year: 2004 ident: 10.1016/j.bbagen.2006.07.006_bib12 article-title: Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl)imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding publication-title: J. Biol. Chem. doi: 10.1074/jbc.M403349200 – volume: 33 start-page: 910 year: 2005 ident: 10.1016/j.bbagen.2006.07.006_bib40 article-title: Possible pathway(s) of testosterone egress from the active site of cytochrome P450 2B1: a steered molecular dynamics simulation publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.105.004200 – volume: 42 start-page: 6370 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib31 article-title: Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes publication-title: Biochemistry doi: 10.1021/bi0273922 – volume: 1545 start-page: 114 year: 2001 ident: 10.1016/j.bbagen.2006.07.006_bib53 article-title: Rational evolution of a medium chain-specific cytochrome P-450 BM-3 variant publication-title: Biochim. Biophys. Acta doi: 10.1016/S0167-4838(00)00268-5 – volume: 42 start-page: 401 year: 2006 ident: 10.1016/j.bbagen.2006.07.006_bib26 article-title: Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an adult AIDS clinical trials group study publication-title: Clin. Infect. Dis. doi: 10.1086/499364 – volume: 300 start-page: 549 year: 2002 ident: 10.1016/j.bbagen.2006.07.006_bib45 article-title: Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.300.2.549 – volume: 339 start-page: 371 issue: Pt. 2 year: 1999 ident: 10.1016/j.bbagen.2006.07.006_bib42 article-title: Roles of key active-site residues in flavocytochrome P450 BM3 publication-title: Biochem. J. doi: 10.1042/0264-6021:3390371 – volume: 100 start-page: 13196 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib11 article-title: An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.2133986100 – volume: 311 start-page: 855 year: 2004 ident: 10.1016/j.bbagen.2006.07.006_bib22 article-title: The functional role of threonine-205 in the mechanism-based inactivation of P450 2B1 by two ethynyl substrates: the importance of the F helix in catalysis publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.104.071670 – volume: 19 start-page: 444 year: 2004 ident: 10.1016/j.bbagen.2006.07.006_bib30 article-title: Functional characterization of single nucleotide polymorphisms with amino acid substitution in CYP1A2, CYP2A6, and CYP2B6 found in the Japanese population publication-title: Drug Metab. Pharmacokinet. doi: 10.2133/dmpk.19.444 – volume: 26 start-page: 1179 year: 1998 ident: 10.1016/j.bbagen.2006.07.006_bib44 article-title: Molecular basis of P450 inhibition and activation: implications for drug development and drug therapy publication-title: Drug Metab. Dispos. – volume: 30 start-page: 86 year: 2002 ident: 10.1016/j.bbagen.2006.07.006_bib39 article-title: Combined three-dimensional quantitative structure–activity relationship analysis of cytochrome P450 2B6 substrates and protein homology modeling publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.30.1.86 – volume: 291 start-page: 176 year: 1991 ident: 10.1016/j.bbagen.2006.07.006_bib2 article-title: Functional expression of mammalian cytochromes P450IIB in the yeast Saccharomyces cerevisiae publication-title: Arch. Biochem. Biophys. doi: 10.1016/0003-9861(91)90121-X – volume: 394 start-page: 21 year: 2001 ident: 10.1016/j.bbagen.2006.07.006_bib33 article-title: The role of cytochrome B1 substrate recognition site residues 115, 294, 297, 298, and 362 in the oxidation of steroids and 7-alkoxycoumarins publication-title: Arch. Biochem. Biophys. doi: 10.1006/abbi.2001.2504 – volume: 279 start-page: 35630 year: 2004 ident: 10.1016/j.bbagen.2006.07.006_bib35 article-title: The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution publication-title: J. Biol. Chem. doi: 10.1074/jbc.M405427200 – volume: 42 start-page: 408 year: 2006 ident: 10.1016/j.bbagen.2006.07.006_bib55 article-title: Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance publication-title: Clin. Infect. Dis. doi: 10.1086/499369 – volume: 15 start-page: 1407 year: 2002 ident: 10.1016/j.bbagen.2006.07.006_bib17 article-title: Substrate routes to the buried active site may vary among cytochromes P450: mutagenesis of the F–G region in P450 2B1 publication-title: Chem. Res. Toxicol. doi: 10.1021/tx020057u – volume: 266 start-page: 22515 year: 1991 ident: 10.1016/j.bbagen.2006.07.006_bib4 article-title: Molecular basis for a functionally unique cytochrome P450IIB1 variant publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)54602-0 – volume: 260 start-page: 16122 year: 1985 ident: 10.1016/j.bbagen.2006.07.006_bib8 article-title: The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(17)36209-9 – volume: 59 start-page: 475 year: 2001 ident: 10.1016/j.bbagen.2006.07.006_bib38 article-title: Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles publication-title: Mol. Pharmacol. doi: 10.1124/mol.59.3.475 – volume: 21 start-page: 474 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib54 article-title: Directed evolution of enzymes for applied biocatalysis publication-title: Trends Biotechnol. doi: 10.1016/j.tibtech.2003.09.001 – volume: 4 start-page: 515 year: 2003 ident: 10.1016/j.bbagen.2006.07.006_bib1 article-title: Transcriptional regulation of cytochrome P4502B genes by nuclear receptors publication-title: Curr. Drug Metab. doi: 10.2174/1389200033489262 – volume: 16 start-page: 1 year: 2005 ident: 10.1016/j.bbagen.2006.07.006_bib36 article-title: In silico modelling of ADMET—a minireview of work from 2000 to 2004 publication-title: SAR QSAR Environ. Res. doi: 10.1080/10629360412331319835 |
SSID | ssj0000595 ssj0025309 |
Score | 2.1176808 |
SecondaryResourceType | review_article |
Snippet | In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure–function through determination of one ligand-free and two... In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure-function through determination of one ligand-free and two... |
SourceID | osti proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 402 |
SubjectTerms | Animals Aryl Hydrocarbon Hydroxylases - chemistry Aryl Hydrocarbon Hydroxylases - genetics BASIC BIOLOGICAL SCIENCES Binding Sites BIOCHEMISTRY BIOPHYSICS Conformation CYP2B Cytochrome P-450 CYP2B6 Cytochrome P-450 Enzyme System - chemistry Cytochrome P-450 Enzyme System - genetics Cytochrome P450 Cytochrome P450 Family 2 CYTOCHROMES Function Humans Models, Molecular Mutagenesis, Site-Directed Mutation Other,OTHER Oxidoreductases, N-Demethylating - chemistry Oxidoreductases, N-Demethylating - genetics Polymorphism, Genetic Structure Structure-Activity Relationship Substrate specificity Thermodynamics |
Title | Structure–function analysis of cytochromes P450 2B |
URI | https://dx.doi.org/10.1016/j.bbagen.2006.07.006 https://www.ncbi.nlm.nih.gov/pubmed/16935426 https://www.proquest.com/docview/68948750 https://www.osti.gov/biblio/910100 |
Volume | 1770 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB7WFdGL-HZ99uC1brtN0ua4LsrqoogP9FbSNEFFWtH14EX8D_5Df4kzbap4EMFToWQgzCQz33Sm3wDsWEQNxoaJr-NM-ixKMrxzXPhCCpNn0jJRjek8PhHDS3Z0za9bMGj-haG2Suf7a59eeWv3puu02X24ve2eU1EP4QQx5FE5DfP2yV4kBR7tyf7haHjy7ZB5NXyF1vsk0PxBV7V5ZRne28JVJYjOUPwWodolXrrfgWgVkA7mYNYhSa9fb3YeWqZYgKl6tuTLAkwPmlFui8DOK5bY50fz8fZOkYys4SnHR-KV1tMv41LfEHXBk3fKeOD19pbg8mD_YjD03bgEX0ciHvvMyhxTzjgPVWI0hnqlGcKhxMjc8jjPE2aETnpSiQxzFmEk2kTGFvGMFjbhQbQM7aIszCp4NoulzDE74SZm2jAVaqMiLbXiVmFY7UDUqCjVjkucRlrcp03T2F1aK5bGXIo0oCK36ID_JfVQc2n8sT5utJ_-OBMpuvs_JNfIWCRFVLiaeoZQDKFRGAQd2G5MmKIdqECiClM-P6UikZS_4YqV2rLf2xQy4ghm1v69pXWYqT8LU_vaBrTR7mYT8cw424KJ3ddwy51aeo7Orkaf4d_0Nw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5kRfQivl2fPXit29okbY66KOtrEVTwFtI0wRVpF10PXsT_4D_0lzjTh4uHZcFrSSDMZGa-6Uy-AThwiBqsCxPfxKn0WZSkaHNc-EIKm6XSMVGO6bzui949u3jgDzPQbd7CUFtl7fsrn1566_pLp5ZmZzgYdG6pqIdwghjyqJyGefssQ_Ml6zz8GPd5IH7gVSmB-bS8eT9XNnmlKVptXtckiMxQTIpPrQJNbjIMLcPR2RIs1jjSO66OugwzNl-BuWqy5PsKzHebQW6rwG5Ljti3F_v9-UVxjHTh6ZqNxCucZ95HhXkk4oJX74bxwDs6WYP7s9O7bs-vhyX4JhLxyGdOZphwxlmoE2sw0GvDEAwlVmaOx1mWMCtMciS1SDFjEVaiRmTsEM0Y4RIeROvQyovcboLn0ljKDHMTbmNmLNOhsToy0mjuNAbVNkSNiJSpmcRpoMWzalrGnlQlWBpyKVRAJW7RBv9317Bi0piyPm6kr_7cCIXOfsrOLVIW7SIiXEMdQ7gNgVEYBG3Yb1SoUA9UHtG5Ld5elUgkZW-4YqPS7PiYQkYcoczWv4-0D_O9u-srdXXev9yGheoHMTWy7UAL74DdRWQzSvfKm_sDPlfzWA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structure-Function+Analysis+of+Cytochromes+P450+2b&rft.jtitle=Biochimica+et+biophysica+acta&rft.au=Zhao%2C+Y.&rft.au=Halpert%2C+J.R.&rft.date=2007-03-01&rft.issn=0006-3002&rft.eissn=1878-2434&rft.volume=1770&rft_id=info:doi/10.1016%2Fj.bbagen.2006.07.006&rft.externalDocID=910100 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon |